{"id": "g9ooyx", "title": "$AZN (AstraZeneca) opportunity to play earnings", "selftext": "Merck released earnings this morning and the company had to lower full year estimates due to COVID effecting demand for physician-administered drug therapeutics. All eyes should be on AstraZeneca as they have an equally large oncology product line of non oral oncology drugs. Furthermore, with business travel restrictions and hospitals preventing pharma sales teams from visiting physicians at this time, it will be hard for AZN to push its newly approved products. All things point to lower FY predictions and a stock price decrease. \n\ntldr; $AZN 50p 5/1", "created_utc": 1588085829.0, "permalink": "/r/wallstreetbets/comments/g9ooyx/azn_astrazeneca_opportunity_to_play_earnings/", "is_self": true}